Please ensure Javascript is enabled for purposes of website accessibility
Cabot Prime Pro Logo
Cabot Prime Pro

Cabot Prime Pro Week Ending October 22, 2021

Cabot Prime Pro Week Ending October 22, 2021

Stock Recommendation Tracker

The Stock Recommendation Tracker is a table that features all of the current recommendations in all of our portfolios. It’s a quick way for you to see what stocks are currently in our portfolios and will highlight new additions or any changes to our recommendations over the previous week. We include this table at the bottom of the Weekly Summary, and provide a link here at the top to the Stock Recommendations Tracker.

Cabot Weekly Review (Video)

In this week’s stock market video, Mike Cintolo sounds a bullish tone, saying the past three weeks have gone about as good as the bulls could have hoped. Earnings season remains a risk, and a near-term wobble wouldn’t surprise him, but just following the evidence, Mike’s been putting money to work and goes through a huge number of stocks and sectors that are acting well today.


Cabot Retirement Club Member Call

FREE MEMBER CALL: October 28, 2021 Sign up now.

The Next Big Technology Revolutions - and How to Profit from Them

FREE WEBINAR: November 18, 2021 Sign up now.

Advisory Services

Cabot Growth Investor

Bi-weekly Issue October 21: Still, the action of the past couple of weeks (combined with many signs that investors have become worried) certainly looks like a bullish change of character. We wouldn’t be buying whole-hog, but we’re putting some more of our cash hoard to work—in the Model Portfolio, we’re averaging up on Asana (ASAN) and buying a full-sized position in CrowdStrike (CRWD), leaving us with a cash position of 24%.

Bi-weekly Update October 14: Remain cautious, but don’t ignore the action of individual stocks. Our Cabot Tides remain negative (neutral at best), but as opposed to much of this year, growth stocks are showing great strength. We still mostly favor staying close to shore, as the market correction could have further to go. But today we’re going to buy a half-sized position in Ambarella (AMBA), which we think is a leading glamour name. That will leave us with around 38% in cash. Details below. We’re also restoring our Buy rating on Cloudflare (NET).

Cabot Top Ten Trader

Movers & Shakers October 22: The market had another constructive week, which by our thinking makes it three in a row. Coming into today, most indexes were up in the 1.5% to 2% range, which keeps the nascent intermediate-term green light (received last week) intact.

Weekly Issue October 18: This year has been about as choppy and tricky as we can remember, so nothing the market would throw at us from here would come as a surprise. That said, there’s no question the snapback of the past couple of weeks has been very encouraging—the major indexes have rebounded beautifully, with many regaining their 50-day lines, and individual stocks (especially growth stocks) have done great, with more and more moving back to (or out above) their prior highs. Mike’s Top Pick is Zscaler (ZS), which has lifted to new price and relative performance highs after a six-week pullback.

Cabot Options Trader and Cabot Options Trader Pro

Note that the current week’s Weekly Update, earnings updates, position updates and stocks on watch are posted on the website in the Market Update section, which is deleted each week.

Cabot Options Trader Market Update October 21: Yesterday it was reported that PayPal (PYPL) was exploring a purchase of Pinterest (PINS). In reaction to this news PYPL stock lost 5% yesterday, and is down another 4.7% today. The analyst community for the most part is not a fan of this deal for PYPL, which could be why the stock has been under so much pressure.

Cabot Options Trader Basic & Pro Earnings October 20: Freeport McMoRan (FCX) will report earnings tomorrow before the market open. Below is the options market’s perception of risk headed into the event.

Cabot Options Trader Basic & Pro Trade Alert October 19: Buy the Marvell Technology (MRVL) February 67.5 Calls (exp. 2/18/2022) for $5.50 or less.

Cabot Options Trader Basic & Pro Stocks on Watch October 18: As we know, having been caught off guard by the Chinese government’s crackdown on Internet companies via our KWEB trade that went south, the stocks in this sector have been a disaster for months. That being said, some of these fallen China Internet stars have been shaping up in the last two weeks, including former Cabot Options Trader favorite (JD), and more recently Baidu (BIDU). And interestingly, BIDU attracted very bullish option activity yesterday targeting a move higher later this month and into November.

Cabot Options Trader Pro Weekly Review October 18: Long positions: KWEB, CSCO, CGC, FCX, JETS, BSX, MS, UBER. Bearish Positions: None

Cabot Options Trader Basic Weekly Review October 18: The market added to recent gains last week, as the S&P 500 had its best week since July. The S&P 500 rose 1.8%, the Dow climbed 1.6%, and the Nasdaq added 2.2%. The rally came on the back of better-than-expected earnings from several well-known stocks. The big banks dominated the earnings calendar and the sector’s pandemic-era trading boom fueled the continued bullishness.

Cabot Undervalued Stocks Advisor

Weekly Update October 20: A few weeks ago, at the annual Morningstar Investment Conference in Chicago, two investing icons debated the merits of value versus growth. On the value side was Rob Arnott, founder and head of Research Affiliates, with Cathie Wood, founder and head of ARK Investment Management, on the growth side. The debate promised to be enlightening, with perhaps some foreshadowing of which style would perform best over the coming months and years.

Monthly Issue October 6: Official inflation numbers are, of course, starting to rise quickly. The August CPI increased 5.3% from a year ago (even as the housing component continues to significantly understate inflation). Curiously, major appliance makers are curtailing production of their lower-priced models to prioritize their more expensive and higher-margin models – this won’t be good for keeping inflation rates low.

Cabot Stock of the Week

Weekly Issue October 18: Tim’s featured stock Snowflake (SNOW), is a hyper-growth stock that has brought the benefits of public clouds (scalable, flexible, etc.) to data management so customers can better understand their data. Unlike many other high-tech data software solutions, Snowflake’s offering isn’t aimed at just the mega enterprises. It is used by a wide range of companies, from small operations of just a few people all the way up to the largest companies in the world.

Cabot Explorer

Bi-weekly Update October 21: Explorer stocks are trending up, with some exceptions. Recent idea Else Nutrition (BABYF) took a hit early last week after raising capital and diluting shareholders. This is a young company and speculative stock. On the other hand, Sea Limited (SE) continued its strength and Cloudflare (NET) is now up 138% so far this year. Novonix (NVNXF) is getting back in form and nudged upward from 4 to 4.4 as it hopefully moves back to its year high, making it one of our best ideas for 2021.

Bi-weekly Issue October 14: A country’s brand is largely framed by the perception of its people, power, reliability and influence. This perception can be just as important as a country’s real economic and military power. In short, a country’s brand largely reflects a country’s character. Carl’s new recommendation Bombardier Inc. (BDRBF), is a global leader in aviation with a niche in private and corporate markets, and is making a splash at this week’s aviation show in Las Vegas. It provides world-class products in passenger comfort, energy efficiency, reliability and safety.

Cabot Small-Cap Confidential

Weekly Update October 21: As we move closer to earnings season for our portfolio holdings (really gets underway the week after next) we see many small-cap growth names (and growth stocks in general) recovering nicely from the drawdowns in late September.

Special Bulletin October 8: Today is something of a battleground day for Accolade (ACCD) given that the stock slid into yesterday’s earnings call near the low end of its 2020 trading range amidst concerns that the Delta variant would challenge the critical selling season, which is underway right now.

Monthly Issue October 7: Tyler’s new recommendation Rani Therapeutics (RANI) is a clinical-stage biotechnology company that is developing an orally administered pill – the RaniPill – to deliver biologics into the body. This pill is designed to give a precise therapeutic dose of treatments that are currently only available with injections. Rani’s platform is different from many other oral pill formulations for injectable biologics because it doesn’t change the drug at all.

Cabot Dividend Investor

Weekly Update October 20: Forget the virus. Forget about the Fed tightening. It’s all about earnings now. Although it’s still very early in the reporting cycle, earnings have been great so far. The market is reacting by recouping last month’s losses and soaring back to within bad breath distance of the all-time high. The positive early earnings are surprising yet unsurprising at the same time.

Monthly Issue October 13: Tom’s featured stock Compass Diversified (CODI), is a holding company that invests in niche middle-market businesses, a segment historically reserved for traditional private equity. It owns ten companies, six in branded consumer businesses and four niche industrial companies. The businesses are unrelated and therefore provide diversification. The branded businesses include companies that make and sell outdoor wear, food warming systems, baseball equipment, diamonds, and baby products. The industrial businesses make circuit boards, magnetic technologies, and custom packaging.

Cabot Marijuana Investor

Update October 13: The good news is that the marijuana industry is growing rapidly, with the leading companies continuing with their programs of store openings and acquisitions. The bad news is that the stocks of these leading companies remain in correction mode, as they have been since February.

Monthly Issue September 29: Since the marijuana sector peaked in February, the Global Cannabis Stock Index has lost 50% of its value. That’s the cost of investing in hot young growth industries. But the fundamentals of the industry remain exceedingly attractive, so there’s no question that eventually, this long slow bottoming process will give way to a new uptrend. In the meantime, our dual focus on the leading companies in the industry (measured by revenues and earnings) and the strongest stocks in the sector (measured by chart strength) will keep us in the stocks that are most likely to lead the next advance.

Cabot Early Opportunities

Monthly Issue October 20: There are a lot of things investors could focus on these days, ranging from potential impacts of supply chain disruptions and labor shortages to the big-picture economic effects of inflation and rising interest rates. But really, for the coming weeks it’s going to be all about earnings season. We’re all looking for insights into how individual companies are being impacted by the aforementioned challenges (and more) and what opportunities they’re successfully chasing down. Tyler’s top pick is Dynatrace (DT).

Special Bulletin October 8: We jumped into Bellring Brands (BRBR) as a trade in September and the stock has slid since. It’s down less than 10%, but the trajectory is clearly not working in our favor and I’m not going to let a trade attempt turn into something significant. We’re moving on. Sell

Cabot Profit Booster

Weekly Issue October 19: The market added to recent gains last week, as the S&P 500 had its best week since July. The S&P 500 rose 1.8%, the Dow climbed 1.6%, and the Nasdaq added 2.2%. The rally came on the back of better-than-expected earnings from several well-known stocks. The big banks dominated the earnings calendar and the sector’s pandemic-era trading boom fueled the continued bullishness. Jacob’s new stock recommendation is Datadog (DDOG).

Cabot Micro-Cap Insider

Weekly Update October 20: P10 Holdings (PIOE) recently announced it will price its (previously telegraphed) IPO in the range of $14 to $16, but there will be a .7 to 1 reverse split. PIOE opened at $11.24 on Tuesday October 12, 2021, equivalent to a $16 post IPO price. Essentially, P10 is uplisting from the OTC market to the NYSE. As part of the IPO (which really should be viewed as a secondary), the company is raising ~$172MM to de-lever and strengthen its balance sheet for additional acquisition opportunities.

Monthly Issue October 13: Rich’s new recommendation Leatt (LEAT) Corporation, is a South African company that designs and manufactures protective equipment for motor bike riders. Despite a revenue compound annual growth rate (CAGR) of 24% from 2017 to 2020, and an EPS CAGR of 165%, the stock trades at a forward P/E multiple of just 13.2x. Insiders own 45% of shares outstanding, and I expect strong growth ahead. My price target of 36 implies significant upside ahead.

Cabot Income Advisor

Weekly Update October 20: Supply chain issues and inflation threaten to spoil the party and limit profits. But earnings have been strong and better than expected so far. Bank earnings were stellar. This week, several other companies including Travelers Companies (TRV), Johnson & Johnson (JNJ), and Procter & Gamble (PG) reported earnings above expectations, suggesting that regular companies will overcome supply chain issues and generate strong profits.

Monthly Issue September 22: The dicey market prognosis creates two issues for the portfolio. One is that it isn’t a great time to buy anything. Stocks aren’t down much yet and the near future looks bleak. The other issue is that the recent downward bias has shrunken call premiums, as less investors are willing to bet on higher prices. Tom’s featured stock AGNC Investment Corp. (AGNC), is a mortgage real estate investment trust that invests predominantly in U.S. Government-backed residential mortgages. It pays a very high dividend yield and makes payments on a monthly basis.

Cabot Turnaround Letter

Weekly Update October 22: We raise our price target on Wells Fargo (WFC). Also, our take on earnings from Baker Hughes (BKR) and Mattel (MAT), comments on Macy’s (M), Credit Suisse (CS) and Western Digital (WDC), and our views on WeWork (WE), Digital World Acquisition Corp (DWAC), the metaverse, FaceBook (FB) and the Boston Red Sox.

Monthly Issue September 29: We look at five interesting turnaround stocks in the transportation industry and four turnaround stocks that trade for less than $11/share. Our new Buy recommendation is TreeHouse Foods (THS), one of the largest contract food manufacturers. Pressure from activist investor JANA Partners could produce strong gains in this undervalued company’s shares.

Ask the Experts

Cabot Micro-Cap Insider

Question: Natural gas prices are skyrocketing I think EPSN was a great pick. I wanted to ask what are your expectations towards IDT earnings that are coming ahead first week of October? After a bull run price has dropped since the choppy market.

Rich: Yes I think EPSN is positioned very well here. The company has 2/3 of its product hedged in the $3/Mcf range, but 1/3 has exposure to the spot market. From November ’21 to March ’22, 30% of production is hedged at ~$3.34/Mcf, but 70% of production is exposed to the soaring spot market.I don’t have much insight into IDT’s upcoming earnings, but I would expect the strong trend to continue although the stock has gotten a little choppier.

Quarterly Cabot Analyst Meeting

The recording of the Cabot Prime Members Meeting with the Analysts from July 14, 2021 is now available for you to listen to at your convenience—click here for access. This private call with our analysts is one of your exclusive Cabot Prime Pro member benefits.

Stock Recommendations Tracker

The table below lists all of the stocks held in any Cabot portfolio.
Updated or revised recommendations from the past week are in purple text.
Stocks added to a portfolio are highlighted in green text.
Closed stock positions in the past week are highlighted in red text.

StockCabot Small-Cap ConfidentialCabot ExplorerCabot Growth InvestorCabot Marijuana InvestorCabot Stock of the WeekCabot Undervalued Stocks AdvisorCabot Dividend Investor
ASANBuy Another Half
CCHWFSee Advisory
CGCSee Advisory
CHPTBuy a 1/2
CRLBFSee Advisory
CURLFSee Advisory
FSRBuy a 1/2
GRWGSee Advisory
GTBIFSee Advisory
IIPRSee Advisory
JUSHFSee Advisory
LLYBuy 1/3
MRVLBuy a 1/2Buy
NETHold a 1/2Buy
NVNXFBuy a 1/2
SEBuy a 1/2Hold
SPCEHold a 1/2
SSOHold 1/2
TCNNFSee Advisory
TPBSee Advisory
TRSSFSee Advisory
VECOBuy a 1/2Buy